RasimAGucalpMD

Oncology • Bronx, NY

Professor, Medicine, Oncology, Albert Einstein College of Medicine

Join to view full profile

Dr. Gucalp is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gucalp's full profile

Already have an account?

Office
MMC Dept of Oncology
111 East 210TH Street
Bronx, NY 10467
Phone+1 718-405-8536

Fax+1 718-798-7474

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1986 - 1990
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1982 - 1984
Hacettepe University FOMClass of 1975

Certifications & Licensure

NY State Medical License 1992 - 2026
TX State Medical License 1992 - 1993
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Start of enrollment: 1988 Apr 01
Completed
Phase 2
BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma Start of enrollment: 2002 Jan 01
Unknown status
Phase 2
Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer Start of enrollment: 2004 May 01
Terminated
Phase 2
Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2006 Apr 01
Completed
Phase 2
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma Start of enrollment: 2010 Sep 01
Terminated
Phase 2
Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer Start of enrollment: 2015 Feb 09
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT).
Nitin Ohri, William R Bodner, Rafi Kabarriti, Viswanathan Shankar, Rasim Gucalp
International Journal of Radiation Oncology, Biology, Physics. 2025-01-23
3 citations
HIV Associated Lung Cancer: Unique Clinicopathologic Features and Immune Biomarkers Impacting Lung Cancer Screening and Management.
Ayse Ece Cali Daylan, Catarina Martins Maia, Shirin Attarian, Xiaoling Guo, Mindy Ginsberg
Clinical Lung Cancer. 2024-03-01
7 citations
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).
Nitin Ohri, Shruti Jolly, Benjamin T Cooper, Rafi Kabarriti, William R Bodner
Journal of Clinical Oncology. 2024-02-10

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Other Languages

Spanish